# Task A03: In Vitro Screening for Antibacterial Activity Against Biodefense and Emerging Infectious Disease Pathogens

> **NIH NIH N01** · COLORADO STATE UNIVERSITY · 2020 · $53,311

## Abstract

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.

## Key facts

- **NIH application ID:** 10074416
- **Project number:** 75N93019D00005-P00003-759301900131-2
- **Recipient organization:** COLORADO STATE UNIVERSITY
- **Principal Investigator:** RICHARD SLAYDEN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $53,311
- **Award type:** —
- **Project period:** 2019-05-01 → 2020-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10074416

## Citation

> US National Institutes of Health, RePORTER application 10074416, Task A03: In Vitro Screening for Antibacterial Activity Against Biodefense and Emerging Infectious Disease Pathogens (75N93019D00005-P00003-759301900131-2). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10074416. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*